Product information

Current status:

Cancelled Post Market

Current status date:

2003-08-01

Original market date: ^{See footnote 1}

1973-12-31

Product name:

TRANXENE CAP 3.75MG

DIN:

00264938 Electronic product monograph is not available

Company:

ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada H4S 1Z1

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05BA05 CLORAZEPATE POTASSIUM

Active ingredient group (AIG) number:^{See footnote5}

0108895001